Investors Snag ACRS Even Lower Than Its Secondary Stock Offering
November 07, 2017 at 11:12 AM EST
Looking back to 89 days ago, Aclaris Therapeutics Inc (ACRS) priced a 3,260,000 share secondary stock offering at $23.02 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..